Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Chataway

Showing results (131-140 of 182) with videos related to

Pageof 19
Sort By:
Neuroimage. Clinical|December 7, 2021
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS techniqueCarmen Tur, Francesco Grussu, Floriana De Angelis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 4, 2015
Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy seriesDavid S Lynch, Zane Jaunmuktane, Una-Marie Sheerin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2024
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trialFloriana De Angelis, James R Cameron, Arman Eshaghi, et al.
Neurology|March 12, 2022
Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple SclerosisAlberto Calvi, Ferran Prados Carrasco, Carmen Tur, et al.
Brain and Behavior|November 27, 2025
The ABILHAND-23 Patient Reported Outcome Measure in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Analysis With the Nine Hole Peg TestSean Apap Mangion, Charles Wade, Tom Williams, et al.
BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 22, 2022
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying TherapiesTjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Improving the efficiency of clinical trials in multiple sclerosisRuth Ann Marrie, Maria Pia Sormani, Sean Apap Mangion, et al.
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
Pageof 19

Showing results (131-140 of 182) with videos related to

Sort By:
Pageof 19
Neuroimage. Clinical|December 7, 2021
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS techniqueCarmen Tur, Francesco Grussu, Floriana De Angelis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 4, 2015
Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy seriesDavid S Lynch, Zane Jaunmuktane, Una-Marie Sheerin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2024
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trialFloriana De Angelis, James R Cameron, Arman Eshaghi, et al.
Neurology|March 12, 2022
Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple SclerosisAlberto Calvi, Ferran Prados Carrasco, Carmen Tur, et al.
Brain and Behavior|November 27, 2025
The ABILHAND-23 Patient Reported Outcome Measure in Secondary Progressive Multiple Sclerosis: A Cross-Sectional Analysis With the Nine Hole Peg TestSean Apap Mangion, Charles Wade, Tom Williams, et al.
BMC Neurology|May 24, 2020
Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)Anthony Feinstein, Maria Pia Amato, Giampaolo Brichetto, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 22, 2022
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying TherapiesTjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2023
Improving the efficiency of clinical trials in multiple sclerosisRuth Ann Marrie, Maria Pia Sormani, Sean Apap Mangion, et al.
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
Pageof 19